Passik, PhD, Steven D., United States

• Journal of Opioid Management Vol. 10 No. 4 (2014): July/August - Articles
  Review article. Opioid analgesics: Does potency matter?
  Abstract
• Journal of Opioid Management Vol. 11 No. 1 (2015): January/February - Articles
  FDA/DEA/PDMP/UDT: Alphabet soup or sensible and integrated risk management?
  Abstract
• Journal of Opioid Management Vol. 13 No. 6 (2017): November/December - Abuse Deterrent Opioids Special Issue - Articles
  Reality and responsibility revisited: Stakeholder accountability in the effort to develop safer opioids
  Abstract  PDF
• Journal of Opioid Management Vol. 1 No. 5 (2005): November/December - Articles
  Monitoring outcomes during long-term opioid therapy for noncancer pain: Results with the Pain Assessment and Documentation Tool
  Abstract  PDF
• Journal of Opioid Management Vol. 2 No. 3 (2006): May/June - Articles
  Reality and responsibility: A commentary on the treatment of pain and suffering in a drug-using society
  Abstract  PDF
• Journal of Opioid Management Vol. 3 No. 2 (2007): March/April - Editorial
  King of Pain: What Elvis’s death tells us about media coverage of celebrities and the pain/addiction interface
  Abstract  PDF
• Journal of Opioid Management Vol. 7 No. 5 (2011): September/October - Articles
  A comparison of methods of administering the Opioid Risk Tool
  Abstract
• Journal of Opioid Management Vol. 5 No. 5 (2009): September/October - Articles
  Chronic opioid therapy issues associated with opioid abuse potential
  Abstract
• Journal of Opioid Management Vol. 11 No. 1 (2015): January/February - Articles
  A primer on definitive gas and liquid chromatography drug testing: What clinicians need to know
  Abstract
• Journal of Opioid Management Vol. 7 No. 3 (2011): May/June - Review Articles
  Current status and evolving role of abuse-deterrent opioids in managing patients with chronic pain
  Abstract
• Journal of Opioid Management Vol. 19 No. 1 (2023): January/February - Articles
  Preliminary validation of the Diversion Risk Scale (DRS): Using environmental and individual factors to predict opioid-related diversion events
  Abstract
• Journal of Opioid Management Vol. 11 No. 1 (2015): January/February - Articles
  Specimen validity testing in urine drug monitoring of medications and illicit drugs: Clinical implications
  Abstract
• Journal of Opioid Management Vol. 16 No. 6 (2020): November/December - Articles
  Concomitant use of benzodiazepines in chronic pain patients adherent to extended-release tapentadol or oxycodone treatment—A retrospective claims analysis
  Abstract
• Journal of Opioid Management Vol. 11 No. 1 (2015): January/February - Articles
  Trends in drug use from urine drug testing of addiction treatment clients
  Abstract
• Journal of Opioid Management Vol. 18 No. 4 (2022): July/August - Articles
  Definitive urine drug test findings in patients prescribed opioids for pain from a large national database
  Abstract  PDF